|Title:||Characteristics of Medical Products Comprising Human Cells, Genes, or Tissues Developed in Japan and the European Union Compared via Public Assessment Reports|
|Author's alias:||笠井, 宏委|
|Keywords:||advanced therapy medicinal products (ATMP)|
regenerative medicine regenerative medicine products
public assessment reports
|Publisher:||Frontiers Media S.A.|
|Journal title:||Frontiers in Bioengineering and Biotechnology|
|Rights:||© 2020 Kurauchi, Kasai and Ito.|
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
|Appears in Collections:||Journal Articles |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.